Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Julia Starkova"'
Autor:
Julius Lukes, Jr, Eliska Potuckova, Natividad Alquezar-Artieda, Ivana Hermanova, Sladjana Kosanovic, Katerina Hlozkova, Meritxell Alberich Jorda, Jan Zuna, Jan Trka, Daniel A. Tennant, Martin Stanulla, Marketa Zaliova, Julia Starkova
Publikováno v:
HemaSphere, Vol 7, Iss 9, p e946 (2023)
Externí odkaz:
https://doaj.org/article/38745fd95b8a406db493f1710ead251c
Autor:
Katerina Hlozkova, Ivana Hermanova, Lucie Safrhansova, Jan Trka, Daniel Tennant, Julia Starkova
Publikováno v:
HemaSphere, Vol 7, p e7288777 (2023)
Externí odkaz:
https://doaj.org/article/ab50c2eb66a44e90ab8ce93efa2b457d
Autor:
Katerina Hlozkova, Maryna Vasylkivska, Martina Zwyrtkova, Matus Kolarik, Eliska Potuckova, Natividad Alquezar Artieda, Marketa Zaliova, Jan Trka, Daniel Tennant, Julia Starkova
Publikováno v:
HemaSphere, Vol 7, p e2903373 (2023)
Externí odkaz:
https://doaj.org/article/f1b70316520b4b029f45f6fea074552d
Autor:
Katerina Hlozkova, Ivana Hermanova, Lucie Safrhansova, Natividad Alquezar-Artieda, Daniela Kuzilkova, Adela Vavrova, Kristyna Sperkova, Marketa Zaliova, Jan Stary, Jan Trka, Julia Starkova
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Childhood T-cell acute lymphoblastic leukemia (T-ALL) still remains a therapeutic challenge due to relapses which are resistant to further treatment. l-asparaginase (ASNase) is a key therapy component in pediatric T-ALL and lower sensitivity
Externí odkaz:
https://doaj.org/article/a56a66429e434579a86547fe963c8f4f
Autor:
Katerina Hlozkova, Alena Pecinova, Natividad Alquezar-Artieda, David Pajuelo-Reguera, Marketa Simcikova, Lenka Hovorkova, Katerina Rejlova, Marketa Zaliova, Tomas Mracek, Alexandra Kolenova, Jan Stary, Jan Trka, Julia Starkova
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Effectiveness of L-asparaginase administration in acute lymphoblastic leukemia treatment is mirrored in the overall outcome of patients. Generally, leukemia patients differ in their sensitivity to L-asparaginase; however, the mech
Externí odkaz:
https://doaj.org/article/3a0f00672d664ae892d8831ce71d96fa
Autor:
Julius Lukes, Jr., Lucie Winkowska, Martina Zwyrtkova, Julia Starkova, Lucie Sramkova, Jan Stary, Jan Trka, Jan Zuna, Marketa Zaliova
Publikováno v:
HemaSphere, Vol 4, Iss 6, p e489 (2020)
Externí odkaz:
https://doaj.org/article/84d2166fda1c4315848bb6b638819edf
Autor:
Marketa Zaliova, Eliska Potuckova, Julius Lukes, Lucie Winkowska, Julia Starkova, Iveta Janotova, Lucie Sramkova, Jan Stary, Jan Zuna, Martin Stanulla, Martin Zimmermann, Beat Bornhauser, Jean-Pierre Bourquin, Cornelia Eckert, Gunnar Cario, Jan Trka
Publikováno v:
Haematologica, Vol 106, Iss 3 (2020)
Externí odkaz:
https://doaj.org/article/9a8f518a73164309b42d3aa460251429
Autor:
Katerina Rejlova, Alena Musilova, Karolina Skvarova Kramarzova, Marketa Zaliova, Karel Fiser, Meritxell Alberich-Jorda, Jan Trka, Julia Starkova
Publikováno v:
Epigenetics, Vol 13, Iss 1, Pp 73-84 (2018)
Homeobox (HOX) genes are frequently dysregulated in leukemia. Previous studies have shown that aberrant HOX gene expression accompanies leukemogenesis and affects disease progression and leukemia patient survival. Patients with acute myeloid leukemia
Externí odkaz:
https://doaj.org/article/a78aec922106463abf4d02495cb9f808
Autor:
Marketa Zaliova, Eliska Potuckova, Lenka Hovorkova, Alena Musilova, Lucie Winkowska, Karel Fiser, Jan Stuchly, Ester Mejstrikova, Julia Starkova, Jan Zuna, Jan Stary, Jan Trka
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
ERG-deletions occur recurrently in acute lymphoblastic leukemia, especially in the DUX4-rearranged subtype. The ERG-deletion was shown to positively impact prognosis of patients with IKZF1-deletion and its presence precludes assignment into IKZF1plus
Externí odkaz:
https://doaj.org/article/b3ac0ac530c4478aaf403b9a1428838a
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
Autor:
Marketa Zaliova, Jan Stuchly, Lucie Winkowska, Alena Musilova, Karel Fiser, Martina Slamova, Julia Starkova, Martina Vaskova, Ondrej Hrusak, Lucie Sramkova, Jan Stary, Jan Zuna, Jan Trka
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Novel biological subtypes and clinically important genetic aberrations (druggable lesions, prognostic factors) have been described in B-other acute lymphoblastic leukemia (ALL) during the last decade; however, due to a lack of studies on unselected c
Externí odkaz:
https://doaj.org/article/83a31a02ffa84184a5cd3db59a615b50